IFPMA code of conduct discusses research motivations and data disclosure
The IFPMA pharma wants members that sponsor clinical trials to do so only if the research develops knowledge and benefits patients.
Archives for September 3, 2012
Danish regulators remove expiry dates from company authorisations
Company authorisations issued to drugmakers in Denmark will not feature expiry dates under new measures designed to reduce regulators admin.
New protein imaging tech could open drug delivery doors, say Arizona State
A new simplified analysis technique of the binding kinetics of membrane proteins could solve a host of drug delivery problems, according to scientists from the Arizona State University.
GE launches range of 'off the shelf' MAb facilities
GE Healthcare has launched an ‘off-the-shelf’ range of modular biomanufacturing facilities that it claims can be designed, constructed and operational in under two years.
Online drug accountability systems will replace paper, says Cenduit
Automated drug accountability systems are becoming “the norm” in clinical trials because they can improve compliance and cut working time drastically, according to Cenduit.